Abstract
With the growing understanding that drugs might induce immune-mediated adverse reactions in patients, immunotoxicity testing of new pharmaceuticals has become an important topic in drug development. The nonclinical assessment of unexpected immune suppression is based on relatively well-standardized and validated assays and animal models. For the evaluation of direct immune stimulation few animal models are available, whilst the development of animal models to assess drug-induced hypersensitivity and in particular autoimmunity is in its infancy.:
Original language | English |
---|---|
Pages (from-to) | 103-9 |
Number of pages | 7 |
Journal | Drug discovery today. Technologies |
Volume | 3 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2006 |